- Dacomitinib 15mg tablets
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Dacomitinib 15mg tablets | Start Date 28-05-2019 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- L01EB07
- BNF Codes
-
- BNF code 08010500
Code | Start Date | End Date |
---|---|---|
37247811000001107 | 28-05-2019 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Dacomitinib monohydrate | Based on Base Substance | Dacomitinib | 15 mg |
Name
Dacomitinib monohydrate
Basis of strength description
Based on Base Substance
BOSS
Dacomitinib
Strength and UOM (Nmr)
15
Strength and UOM (Dmr)
Parent Products
-
VTMDacomitinib
-
VMP(Current) Dacomitinib 15mg tablets
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
30 tablet |